Filing Flows › Marchex (MCHX) › R&D spending
Marchex (MCHX) R&D spending by quarter
Marchex's R&D spending was $2.0M in Q2 2026 (second quarter 2026), -17% from Q1 2026. Over the last 7 quarters it ranged from $2.0M (Q2 2026) to $2.8M (Q4 2024).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $2.0M | -17% | -20% |
| Q1 2026 | $2.4M | +9% | -10% |
| Q4 2025 | $2.2M | -7% | -22% |
| Q3 2025 | $2.4M | -5% | — |
| Q2 2025 | $2.5M | -6% | — |
| Q1 2025 | $2.7M | -6% | — |
| Q4 2024 | $2.8M | — | — |
Q2 2026 at a glance
Marchex, Q2 2026: revenue $11.0M (-6% year over year), operating margin -3.1%, net loss $408K, operating cash flow −$649K. The chart follows the revenue to costs, profit and cash.
Questions
What is Marchex's R&D spending?
Marchex's R&D spending was $2.0M in Q2 2026 (second quarter 2026), -17% from Q1 2026.
How has Marchex's R&D spending changed?
Over the last 7 quarters it ranged from $2.0M (Q2 2026) to $2.8M (Q4 2024).